CheckMyRecalls

Imprimis NJOF, LLC recalls…

Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac and 1 more

Published
30 Jul 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Sub-Potent Drug: Subpotent assay results during stability testing.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.

Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01

Brand / company
Imprimis NJOF, LLC
Codes / lots
Lot: 25MAR032, Exp. 07/16/2025. | Lot: 24DEC017, Exp. 07/12/2025.
Distribution
Nationwide in the USA
Recall status
Completed

Source: U.S. Food and Drug Administration, published 30 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.